News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Agenus‘s latest data from the clinical trial of BOT/BAL in refractory sarcomas at ESMO24
Photo taken from Agenus/LinkedIn
Sep 10, 2024, 13:38

Agenus‘s latest data from the clinical trial of BOT/BAL in refractory sarcomas at ESMO24

Agenus shared on LinkedIn:

“The Agenus team is headed to Barcelona for ESMO24.

This Friday, catch the latest data from our clinical trial of botensilimab and balstilimab in refractory sarcomas.

View the presentation details here.”

Proceed to video attached to post.
Source: Agenus/LinkedIn

Agenus Balstilimab botensilimab cancer ESMO ESMO24 OncoDaily Oncology refractory sarcomas
Special Coverage
Positive
Apr 18, 2025, 12:14
2025 ASCO Annual Meeting Merit Award and Special Merit Award recipients
Insight
Apr 18, 2025, 11:51
Applications for 2025 Home Away From Home program are now open - Foundation S
Insight
Apr 18, 2025, 11:31
New Whitepaper Explores Cardiovascular Risks of ADT in Prostate Cancer - International Cardio-Oncology Society
Blog
Apr 18, 2025, 11:18
TLC Conference Thanks its Incredible Faculty for Making Texas Lung 25 a Success
Blog
Apr 18, 2025, 11:12
Donde Quiero Estar Foundation highlights the real barriers people with cancer face in Argentina - UICC
Blog
Apr 18, 2025, 11:05
Dean Crowe: DOD Medical Research Program has funded $317M in funding for pediatric and AYA cancers
Blog
Apr 18, 2025, 10:55
Penilla Gunther: Thank you ESOT for bringing this topic for discussion
Blog
Apr 18, 2025, 10:41
Yan Leyfman: Promising news in Parkinson's research - results from a phase I clinical trial
Blog
Apr 18, 2025, 10:26
Maria (Masha) Babak: We’re Beyond Flattered by the Warm Welcome from Satbayev University
Societies
Apr 18, 2025, 10:17
DiSPLeN webinar on Acute Lymphoblastic Leukemia: Strategies to reduce relapse risk in low resource settings - SIOP
Blog
Apr 18, 2025, 10:08
Julie Freischlag will retire at the end of 2025 as CEO of Atrium Health Wake Forest Baptist
Societies
Apr 18, 2025, 09:49
ASCO Guideline update: Sentinel lymph node biopsy in early-stage breast cancer